GlassScriptPhysician profile
Shan Sharif
NPI 1972943488
$3,776.48
in general payments reported to CMS, 2019-2025
14 companies · $296 in 2025
The $296 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,959 · 2020: $88.31 · 2021: $32.49 · 2022: $891 · 2023: $415 · 2024: $93.77 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529 · Education: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.16 |
| Education | $275.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,334.81 | 2019-2023 | Persona |
| Depuy Synthes Sales INC. | $394.47 | 2019 | |
| Bioventus LLC | $181.01 | 2022-2025 | Exogen Ultrasound Bone Healing System, Gelsyn-3, Durolane |
| Microport Orthopedics INC | $171.13 | 2022 | |
| Stryker Corporation | $147.06 | 2019-2024 | Mako |
| Sanara Medtech INC. | $122.47 | 2025 | Biasurge |
| Smith+Nephew, INC. | $104.75 | 2020-2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Renasys Touch, Pico 14 |
| Pacira Therapeutics, INC. | $94.46 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $88.63 | 2019-2025 | Euflexxa |
| Heron Therapeutics, INC. | $57.60 | 2022-2023 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $31.34 | 2025 | |
| Pfizer INC. | $18.46 | 2019 | |
| Vericel Corporation | $17.73 | 2023 | Maci |
| Heraeus Medical, LLC. | $12.56 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shan Sharif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.